Parkinson's disease
Conditions
Interventions
Study design
This is a randomized controlled clinical trial. The study will be submitted to the Ethics Committee of the Institute of Neurology Deolindo Couto - Federal University of Rio de Janeiro (IN
E02.190.599.280
E02.190.599
Sponsors
Universidade Federal do Rio de Janeiro
Instituto de Neurologia Deolindo Couto - INDC
Eligibility
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: Adults with idiopathic Parkinson's disease diagnosed by a neurologist; Patients classified into stages 1 to 3 of disability on the Modified Hoehn & Yahr scale; Being on stable antiparkinsonian medication; Montreal Cognitive Assessment (MoCA). No specific cutoff point will be adopted, but identification, by the evaluator, of the patients' ability or not to obey verbal commands.
Exclusion criteria
Exclusion criteria: Presence of other associated neurological diseases; Important change in understanding and carrying out the tasks present in the MoCA; Rheumatic diseases in the acute phase; Previous history of spinal surgeries using osteosynthesis and arthrodesis-type procedures; Patients classified as stages 4 and 5 of disability on the Modified Hoehn & Yahr scale.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Trunk flexibility will be assessed by the sit and reach test with bench is commonly used in clinical environment with the purpose of evaluating the flexibility of the hamstring muscles and lumbar region (LEMMINK et al., 2003). The patient then sits in front of the platform, with the lower limbs fully extended, slightly apart, feet pointed towards the ceiling and resting on the platform. The evaluator can assist by holding the patient's knees in place. Then, the patient is instructed to support their hands overlaid and palms towards the ground, with their upper limbs extended, and lean forward 4 times, maintaining the position for a few seconds. The evaluator then records the score (WELLS and DILLON, 1952). This evaluation, in addition to being practical and quick, has sufficient reliability for your proposal. When compared with the Leighton flexometer (FLEXO), considered the gold standard, it presents a strong association for females (r=0.84) and males (r=0.91) (PETREÇA et al., 2011). | — |
Secondary
| Measure | Time frame |
|---|---|
| The Timed Up and Go test is an excellent predictor of falls in the elderly, in addition to demonstrating the effectiveness of the treatment. It has excellent reliability, intra-examiner (ICC=0.95) and inter-examiner (ICC=0.98), in addition to great cost-benefit as it has low cost and short evaluation time (FIGUEIREDO et al., 2007). The test consists of measuring, in seconds, the time it takes the patient to get up from a chair after the verbal command, with an approximate height of 46cm, walk a distance of 3 meters safely and comfortably, turn 180 degrees, walk again towards the chair and sit down (figure (PODSIADLO and RICHARDSON, 1991). The longer the time, the greater the association between falls and disease progression. During the test, the patient can use, if necessary, auxiliary gait devices, however , without any physical assistance from the evaluator.The patient is instructed to perform the test once, without being timed, to become familiar with the movements (PODSIADLO and RICHARDSON, 1991; NOCERA et al., 2013). As technology advances, new instruments have become available for more accurate and reliable analysis. Currently, the G-WALK® is one of the devices used for the Timed Up and Go test. Easy to use, the sensor is used on the patient, in the lumbosacral region, and communicates via bluetooth to a computer with its own software to perform the analysis (D'ADDIO et al., 2019). With the use of the G-WALK® sensor, it will be possible to determine the time in the phases of the activity, namely: sitting to standing, forward gait, pivoting, backward gait and standing to seated (Figure 2). In a 2019 study, the G-WALK® validity proved to be excellent with regard to speed, cadence, step fulfillment and step duration (ICC = 0.88-0.97). Regarding the test-retest reliability, it also showed an excellent result (ICC=0.85-0.99) (De RIDDER et al., 2019).;The Mini BESTest aims to assess dynamic balance in individuals with PD. Validated in Brazil, it takes an average | — |
Countries
Brazil
Outcome results
None listed